Genomic Analysis of L5178Y tk+/- Cells and their Induced tk-/- Mutant Colonies
Poster Jan 24, 2017
JND Battey, DJ Smart, NS Sierro, D McHugh, P Vanscheeuwijck, MC Peitsch and NV Ivanov
The genetic basis that underpins the mouse lymphoma assay (MLA) is ostensibly well understood; inactivation of the functional thymidine kinase (tk+) allele in L5178Y cells via mutation or deletion induces trifluorothymidine (TFT) resistance and tk-/-mutants can be selected for against a background of tk+/- wild-type cells via TFT-mediated enrichment (Clements. 2000).
• However, despite its widespread use over the past 20 years for hazard identification purposes, few studies have sought to characterise in greater detail the colonies of cells which propagate as a result of mutagenesis in the assay.
• The advent of whole genome sequencing has the potential to enhance mutagenicity testing since genetic changes can now be investigated with high level of detail at the genome level.
• Next generation sequencing (NGS) technology was used to sequence the genomes of:
a) an L5178Y cell line frequently used in MLA studies.
b) Tk-/- mutant colonies induced by two prototypical mutagens in the assay.
• The goal of this pilot study was to exploit NGS technology with a view to shedding new light on the genome of cells used in the MLA, as well as the changes induced as a result of the exposure to mutagens.
Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. To achieve high-end multiplexing capacity on standard Real Time PCR machines, Anapa Biotech has developed the MeltPlex® technology (see box on right).READ MORE
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE